
Class Action Lawsuit Alerts And News Information
Ortho Evra Lawsuit
- Details
- Parent Category: Lawsuit News Alerts
- Category: Class Action Lawsuit Alerts And News Information
Ortho Evra Lawsuit
Ortho Evra Side Effects Lawsuit
Ortho Evra contraceptive skin patch by Johnson & Johnson’s subsidiary Ortho-McNeil has been popular since November 2001. The patch contains a combination of hormones that prevents ovulation in females. It also causes changes in cervical mucus, which, in turn, prevents sperms from reaching the uterus. However, Ortho Evra has serious side effects. According to an Associated Press investigation report, the hormonal contraception patch triples the risk of developing life-threatening blood clots. The serious side effects of the drug include deep vein thrombosis, strokes, pulmonary embolisms, heart attacks, and deaths.
Ortho Evra Complaints and Warnings
According to a study conducted by the FDA in 2004, Ortho Evra led to a three-fold increase in blood clot-related fatal incidents, such as pulmonary embolisms, strokes, heart attacks, and deaths. The reports, made public by the Associated Press in July 2005, claimed that there were at least 23 Ortho Evra deaths, including 17 caused by blood clots until 2004. The study was also apprehensive that the actual side effects were more widespread as the post-marketing reviews covered only 1-10 percent patch users.
The first known Ortho Evra fatality was reported in April 2004. Autopsy of an 18-year-old Manhattan fashion student revealed a blood clot in the lung. The victim was using Ortho Evra and the medical examiner blamed the side effects of the birth control patch for the young woman's death. Another woman, a 25 year-old-mother of three, died of blood clots in her brain. The medical reports held hormones released by Ortho Evra responsible for the death.
In November 2005, the FDA ordered the manufacturer to modify labels on the drug reflecting the increased risk of blood clots and other severe side effects. An advisory issued by Ortho McNeil within days warned that the patch exposed users to 60% more estrogen than pills, which could lead to serious health risks. In March 2006, the FDA announced further review of Ortho Evra and asked label update on the package following a comparative study on the side effects of the patch and other birth control pills. According to the research, the excessive hormones in the patch do not dilute during the digestive process, unlike other pills. They are absorbed directly into the blood stream and cause higher concentration of estrogen, which puts users at a greater risk of clots, thrombosis, and heart strokes.
The consumer advocacy group Public Citizen filed a petition signed by 80,000 individuals to FDA demanding recall of Ortho Evra in May 2008. The petition mentioned cases of unreasonable blood clot and other serious health problems that the birth control patch caused within six months of taking it.
Ortho Evra Side Effects
Blood Clots:
Thromboembolic risks are the most documented side effect of Ortho Evra. The patch increases level of estrogen and progestin hormones in the blood. It releases 60 percent more estrogen compared to birth control pills, and this directly enters the patient’s blood stream, putting them at a greater risk of developing blood clots. Most of the Ortho Evra side effect victims are diagnosed with deep vein thrombosis and pulmonary embolism. Blood clots mostly develop in a deep vein in the pelvic region or legs. It breaks off and travels upward to the lungs, which can cause major artery blocks.
Bextra Lawsuit Attorney
- Details
- Parent Category: Lawsuit News Alerts
- Category: Class Action Lawsuit Alerts And News Information
Bextra Lawsuit Attorney
Bextra Lawsuit Attorney
Pfizer withdrew Bextra from the U.S. market in April 2005 on the recommendation of the FDA. Introduced in November 2001, this non-steroidal anti-inflammatory drug was used to treat pain, stiffness, and inflammation associated with arthritis and other ailments. However, a number of research reports and government reviews held the drug responsible for causing rare skin reactions and increased risk of fatal cardiovascular problems in users.
Bextra Complaints
Bextra was the second Cox-2 inhibitor to be withdrawn from the market after the Vioxx recall in 2004. Some of the side effects of the drug includes increased risk of heart attack, stroke, rare skin disease called Stevens–Johnson syndrome.
In October 2004, Pfizer acknowledged the cardiovascular side effects of Bextra. A report presented to the American Heart Association also highlighted that patients using Bextra were 2.19 fold more likely to suffer heart attack or stroke. A study published by the University of Pennsylvania in November claimed that Bextra posed greater risk of heart attack and stroke than Vioxx, which was withdrawn a month before the report had been made public.
In December 2004, the FDA issued a public health advisory asking doctors to limit use of Bextra and diagnose heart patients properly before prescribing the drug. Four months later, the federal regulator ordered Pfizer to immediately stop selling Bextra, citing major heart and skin problems caused by the drug. The European Union and Canada also suspended the sale of the drug with immediate effect. In December 2005, Health Canada banned Bextra on the recommendations of an expert panel.
In March 2009, a former sales manager from Boston pleaded guilty to selling Bextra inappropriately. She had directed 100 sales representatives working under her supervision to promote the drug for reasons rejected by the FDA. About half a dozen whistleblowers followed the suit and disclosed the unlawful practices adopted by Pfizer for marketing Bextra to the federal investigators.
Bextra Side Effects
Skin Disorders
The FDA has received reports of 87 cases of severe skin reactions, including four deaths, linked to Bextra. Stevens-Johnson Syndrome, a toxic epidermal necrolysis disorder, is the most prominent side effect of the drug. Many patients found themselves affected with the syndrome within two weeks of taking the drug. This complex syndrome affects the skin and mucous membranes, leading to rashes, mucosal lesions, and cell death.
Cardiovascular Side Effects
Facebook Class Action Lawsuit
- Details
- Parent Category: Lawsuit News Alerts
- Category: Class Action Lawsuit Alerts And News Information
Facebook Lawsuit
Facebook Privacy Lawsuit
Botox Side Effects Lawsuit Attorney
- Details
- Parent Category: Lawsuit News Alerts
- Category: Class Action Lawsuit Alerts And News Information
Botox Side Effects Lawsuit Attorney
The New Jersey Assembly Health and Senior Services Committee approved a bill on May 19th proposing a ban on injecting Botox to people younger than 18. The bill prohibits minors from taking botulinum toxin injections for cosmetic purposes unless a doctor prescribes them for medical problems. It cites a report by the American Society for Aesthetic Plastic Surgery that warns of large-scale use of these injections by teenagers and concomitant side effects. It followed the widely published news of a California mother giving Botox injections to her 8-year-old daughter to prepare her for a beauty pageant contest. The San Francisco Human Services Agency began an investigation and the mother was relieved of the responsibility of the custody of the child after the incident sparked protests from the medical community and child right activists.
Botox is used to treat strabismus, facial spasms, and neurological disorders by preventing abnormal muscle contractions. Its cosmetic use has been very popular as the botulinum toxin protein smoothes facial wrinkles. However, if not carefully targeted, the drug can lead to serious side effects, including death.
Botox Side Effects Complaints
The FDA allowed Allergan to manufacture and distribute Botox in 1989 for therapeutic use in patients above 12 years. It approved its cosmetic use in April 2002. However, the drug was linked to deaths and several other harmful side effects soon. A report in the Journal of American Academy of Dermatology’s September 2005 issue revealed that about 28 individuals had died due to Botox between 1989 and 2003. This led to demand for investigations, which revealed that Botox could spread to other areas in the body and impact them. The FDA admitted in February 2008 that the drug was responsible for serious adverse reactions, such as respiratory failure and death.
In April 2009, the FDA announced updated
Chase Class Action Lawsuit
- Details
- Parent Category: Lawsuit News Alerts
- Category: Class Action Lawsuit Alerts And News Information
Chase Class Action Lawsuit
More Articles...
Free Case Review
Lawsuit Cases Popular Today
Latest Lawsuit List ( Sample List )
- Arizona Accident Attorney Lawsuit
- Mastectomy Side Effects Lawsuit Breast Cancer Lawsuit
- Zocor Side Effects Lawsuit Attorney
- Walmart Class Action Lawsuit
- Cymbalta Side Effects Lawsuit Attorney
- Cipro Side Effects Lawsuit
- Bactrim Side Effects Injury Lawsuits
- Coumadin Side Effects Lawsuit Information
- Levaquin Side Effects Lawsuit Information
- Carboplatin Side Effects Lawsuit Information
- Zestril Side Effects Lawsuit Information
- Pradaxa Side Effects Lawsuit Complaints
- Most Reported Drug Side Effects
- Stryker Rejuvenate Hip Replacement Implant Recall Lawsuit
- GranuFlo Lawsuit and NaturaLyte Lawsuit
- DePuy Metal On Metal Hip Implant Lawsuit News
- Baby Infant Nap Nanny Recall Lawsuit
- AIG Rejects Shareholder Lawsuit
- Employment Wage Overtime Lawsuit
- Mirena IUD Lawsuit Mirena Birth Control IUD Recall Lawsuit
Recent Lawsuits
Do I Have A Lawsuit Lawyer Attorney Litigation News & Information
-
Arizona Accident Attorney Lawsuit
-
Mastectomy Side Effects Lawsuit Breast Cancer Lawsuit
-
Zocor Side Effects Lawsuit Attorney
-
Most Reported Drug Side Effects
-
DePuy Metal On Metal Hip Implant Lawsuit News
-
Hip Replacement Implant Recall Lawsuit Attorney Hip Implant Side Effects
-
Stryker Rejuvenate Hip Recall
-
Hip Replacement Recall Lawsuit Stryker Biomet Wright Smith Nephew Hip Implant Recall Lawsuit Attorney
-
DePuy Hip Replacement Recall Lawsuit
-
Hip Replacement Implant Lawsuit Attorney

